Pyridoxine

Pyridoxine

SCHEMBL8733463

Cc1ncc(CO)c(CO)c1O.Cl.O=S(=O)(O)O.P.[MgH2]

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Pyridoxine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.75
▸ ALDH1A1 P00352 4/20 0.75
▸ HPGD P15428 4/20 0.75
▸ HSD17B10 Q99714 1/20 0.75
▸ LMNA P02545 4/20 0.59
▸ TRIM24 O15164 1/20 0.56
▸ TRIM33 Q9UPN9 1/20 0.56
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ AOX1 Q06278 1/20 0.54
▸ PDXK O00764 3/20 0.50
▸ CA1 P00915 3/20 0.47
▸ CA2 P00918 3/20 0.47
▸ CA9 Q16790 3/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ GAA P10253 2/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridoxine SCHEMBL4803163 0.95 KDM4E (0.83) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL1545925 0.94 KDM4E (0.80) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL5370659 0.88 HPGD (0.96) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL42293 0.88 KDM4E (0.96) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL444525 0.88 KDM4E (0.96) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL3383552 0.88 KDM4E (0.96) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL3332830 0.88 KDM4E (0.96) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL8992241 0.88 KDM4E (0.96) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL15769549 0.88 KDM4E (0.96) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL7588196 0.88 KDM4E (0.96) KDM4EALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0814816-A1 COMPOSITIONS FOR THE TREATMENT OF MIGRAINE, CONTAINING POTASSIUM, MAGNESIUM AND PYRIDOXINE Piper, Edwina, Margaret (GB) 1998-01-07 — — EP disclosed
WO-1997026897-A1 COMPOSITIONS FOR THE TREATMENT OF MIGRAINE, CONTAINING POTASSIUM, MAGNESIUM AND PYRIDOXINE PIPER EDWINA MARGARET (GB) 1997-07-31 — — WO disclosed
Send feedback